XOMA

XOMA is a U.S. biotechnology company headquartered in Oakland, California. As a smaller company with 37 employees, XOMA has differentiated itself by focusing on acquiring royalty and milestone rights associated with pre-commercial therapeutic candidates. XOMA's business model revolves around providing non-dilutive and non-recourse funding to biotechnology companies by purchasing the potential future economics tied to their promising drug candidates. This allows the sellers to continue developing their internal drug programs or use the funding for general corporate purposes without sacrificing equity. XOMA's extensive and growing portfolio of royalty and milestone assets offers investors exposure to a diversified range of therapeutic candidates in development. The company actively monitors its portfolio, seeking opportunities to maximize the value of its investments. For more information about XOMA, its portfolio, and potential investment opportunities, please visit www.xoma.com.